ML

CH 1 - Introduction to Pathophysiology

Pathophysiology

  • Study of the functional changes produced by injury, disorder, or disease.
  • Integrates knowledge from related sciences:
    • Pathology (structural changes)
    • Anatomy & Physiology (normal structure/function)
    • Biology (cellular & molecular basis)
    • Microbiology (microorganisms)
    • Chemistry (biochemical reactions)

Disease

  • Defined as functional impairment of cells, tissues, organs, or systems.
  • Broadly encompasses:
    • Injuries (e.g., burns, fractures)
    • Disorders (e.g., genetic metabolic errors)
    • Illnesses (subjective experience of being unwell)
    • Syndromes (recognizable clusters of findings, e.g., Down syndrome)

Pathogenesis

  • Describes the origination & development of disease.
  • Captures the timeline from the initial trigger to the first clinical presentation.
  • Considers risk factors:
    • Modifiable: lifestyle, diet, environmental exposures
    • Non-modifiable: age, genetics, ethnicity

Etiology

  • Specifies the precise cause of a disease.
  • Categories:
    • Pathogen: disease-causing microorganism (e.g., Mycobacterium tuberculosis)
    • Multifactorial: >1 contributing cause (e.g., hypertension)
    • Idiopathic: cause unknown
    • Nosocomial: acquired in a healthcare setting (e.g., MRSA post-surgery)
    • Iatrogenic: unintentionally induced by medical therapy (e.g., chemotherapy-induced anemia)

Clinical Manifestations

  • Collective term for presenting signs & symptoms.
  • Terminology distinctions:
    • Signs: objective, measurable (fever, rash)
    • Symptoms: subjective, reported by patient (pain, fatigue)
  • Patterns & distribution:
    • Local vs. Systemic (e.g., cellulitis vs. sepsis)
    • Acute, Subacute, Chronic (based on duration)
    • Remission (↓ severity) vs. Exacerbation (↑ severity)
    • Asymptomatic: disease present, no noticeable manifestations

Diagnosis, Prognosis, & Treatment

  • Diagnosis: the disease label, assigned using diagnostic criteria (objective & subjective data, lab tests, imaging).
  • Prognosis: predicted course & outcome.
    • Morbidity: disease impact on quality of life/function
    • Mortality: likelihood of death
  • Treatment: interventions aimed at cure, symptom relief, or palliative goals; guided by evidence & patient values.

Concept Map (Mechanisms to Care)

  • Etiology → Pathogenesis → Clinical Manifestations (Signs/Symptoms) → Diagnosis → Treatment
  • Feedback loops exist: treatment modifies pathogenesis & manifestations.

Individual Health Perspective

  • Considers the whole person—body, mind, spirit.
  • Health–Illness Continuum:
    • Health: perceived wholeness, optimal functioning
    • Illness: state of suffering/distress
  • Homeostasis: physiologic equilibrium the body strives to maintain.

Population Health & Epidemiology

  • Epidemiology studies disease patterns in groups.
  • Core metrics:
    • Incidence (new cases): \text{Incidence} = \frac{\text{New cases during period}}{\text{Population at risk}} \times 10^n
    • Prevalence (existing cases): \text{Prevalence} = \frac{\text{All existing cases}}{\text{Total population}} \times 10^n
  • Global classifications:
    • Endemic: routinely found in a region (e.g., malaria in parts of Africa)
    • Epidemic: sudden ↑ above expected levels
    • Pandemic: worldwide spread (e.g., COVID-19)
  • Oversight & data collection by the World Health Organization (WHO).

Prevention Levels

  • Primary Prevention: stop disease before it occurs (vaccination, smoking cessation).
  • Secondary Prevention: early detection & prompt treatment (mammography, BP screening).
  • Tertiary Prevention: rehabilitation to limit complications/progression (stroke rehab, diabetic foot care).

Evidence-Based Practice (EBP)

  • Care aligned with current, cumulative research + expert clinical judgment + patient preferences.
  • Key characteristics:
    • Synthesizes multiple studies—not single reports.
    • Applies across the spectrum of human variation.
    • Requires ongoing critical appraisal & lifelong learning.

Human Diversity Factors Influencing Pathogenesis

  • Gender: hormonal & chromosomal influences (e.g., autoimmune prevalence in females)
  • Age: developmental stage affects susceptibility & response.
  • Race / Ethnicity: genetic predispositions, cultural practices.
  • Locale: urban vs. rural exposures, environmental toxins.
  • Socioeconomic Status: access to care, nutrition, stress levels.

Functional Concepts of Altered Health

  • Concept: broad idea applicable to multiple diseases (e.g., inflammation, oxidative stress).
  • Grouping of concepts forms a conceptual approach—facilitates applying general mechanisms to specific disorders, aiding comprehension & memory.